rss
BMJ Case Reports 2016; doi:10.1136/bcr-2015-213949
  • CASE REPORT

Adjunctive vagus nerve stimulation for treatment-resistant bipolar disorder: managing device failure or the end of battery life

  1. José V Pardo1,2
  1. 1Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota, USA
  2. 2Minneapolis Veterans Health Care System, Minneapolis, Minnesota, USA
  1. Correspondence to Professor José V Pardo, jvpardo{at}umn.edu
  • Accepted 21 February 2016
  • Published 7 March 2016

Summary

The vagus nerve stimulation (VNS) device is used not only to treat refractory seizure disorders but also mood disorders; the latter indication received CE Mark approval in 2001 and Food and Drug Administration approval in 2005. Original estimates for the end of battery life (EOBL) were approximately 6–10 years. Many neuropsychiatric patients have or will soon face EOBL. A patient with severe, life-threatening, treatment-resistant bipolar disorder underwent 9 years of stable remission following 20 months of adjunctive VNS. The device ceased operation at EOBL. Because of logistical issues, re-initiation of VNS was delayed over several months. The patient relapsed with depression, mania and mixed states, and regained remission 17 months after device replacement. This case dictates prudence in managing stable patients in remission with VNS. If the device malfunctions, urgent surgical replacement is warranted with subsequent rapid titration to previous parameters as tolerated. Several months’ delay may trigger relapse and prove difficult to re-establish remission.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article